Perfil
Thomas E.
Gerson served as Chief Financial Officer at Interleukin Genetics, Inc. in 2007, followed by similar roles at Gilead Connecticut, Inc., HistoRx, Inc., Intelligent Medical Devices, Inc., and CaroGen Corp.
He received his undergraduate degree from Boston College and his MBA from The University of Chicago.
Antiguos cargos conocidos de Thomas E. Gerson.
| Empresas | Cargo | Fin |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Director Financiero/CFO | 21/09/2007 |
CaroGen Corp.
 CaroGen Corp. BiotechnologyHealth Technology CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT. | Director Financiero/CFO | - |
Intelligent Medical Devices, Inc.
 Intelligent Medical Devices, Inc. Pharmaceuticals: MajorHealth Technology Intelligent Medical Devices, Inc. engages in the designs development and manufacture of platform-agnostic, regulatory-cleared molecular diagnostic tests. The company was founded by Alice A. Jacobs Nesselrodt in 2000 and is headquartered in Waltham, MA. | Director Financiero/CFO | - |
HistoRx, Inc.
 HistoRx, Inc. Medical SpecialtiesHealth Technology HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA. | Director Financiero/CFO | - |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Director Financiero/CFO | - |
Formación de Thomas E. Gerson.
| Boston College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
HistoRx, Inc.
HistoRx, Inc. Medical SpecialtiesHealth Technology HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA. | Health Technology |
Intelligent Medical Devices, Inc.
Intelligent Medical Devices, Inc. Pharmaceuticals: MajorHealth Technology Intelligent Medical Devices, Inc. engages in the designs development and manufacture of platform-agnostic, regulatory-cleared molecular diagnostic tests. The company was founded by Alice A. Jacobs Nesselrodt in 2000 and is headquartered in Waltham, MA. | Health Technology |
CaroGen Corp.
CaroGen Corp. BiotechnologyHealth Technology CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas E. Gerson
